OUP Management Company’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

OUP Management Company’s Portfolio CYT Stock Details CYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$6.99M	Hold	2,459,572	–	–	15.71%	3
2023 Q2	$6.39M	Hold	2,459,572	–	–	10.91%	4
2023 Q1	$4.48M	Hold	2,459,572	–	–	8.93%	5
2022 Q4	$4.06M	Sell	2,459,572 -10,000	-0.4%	-$16K	6.63%	6
2022 Q3	$4.74M	Sell	2,469,572 -5,000	-0.2%	-$13K	7.38%	6
2022 Q2	$7.4M	Hold	2,474,572	–	–	10.18%	5
2022 Q1	$9.33M	Hold	2,474,572	–	–	7.1%	6
2021 Q4	$28.1M	Buy	+2,474,572	New	+$37.7M	12.68%	2

Other funds holding CYT

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

VAS

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

OUP Management Company's CYT Position: Q3 2023 in Review

OUP Management Company held its Cyteir Therapeutics, Inc. Common Stock (CYT) position steady in Q3 2023 at 2,459,572 shares worth $6.99M. The position accounts for 15.71% of the portfolio, ranked #3.

OUP Management Company first reported a position in CYT in Q4 2021 and has held it in 8 quarters since. The position peaked at $28.1M in Q4 2021. 41 funds tracked by Wall St. Rank hold CYT as of Q3 2023.

OUP Management Company held 2,459,572 shares of Cyteir Therapeutics, Inc. Common Stock worth $6.99M as of Q3 2023.
OUP Management Company left its Cyteir Therapeutics, Inc. Common Stock share count unchanged in Q3 2023.
Cyteir Therapeutics, Inc. Common Stock made up 15.71% of OUP Management Company's portfolio in Q3 2023, its #3 holding.
OUP Management Company first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q4 2021 and has held it in 8 quarters since.
OUP Management Company's Cyteir Therapeutics, Inc. Common Stock position peaked at $28.1M in Q4 2021.
41 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q3 2023.

Based on OUP Management Company's 13F filing for Q3 2023, filed 9 Nov 2023.